The Effect of Aromatherapy Massage on Sleep Quality

Not Applicable

Recruiting

• Conditions: Respiratory Disease; Respiratory Failure; Stroke, Ischemic; Diabetes Mellitus; Pneumonia
• Interventions: Other: Intervention 2 Group; Other: Placebo Control Group; Other: Intervention 1 Group

• Registration Number: NCT06295900
• Lead Sponsor: Nilgün Erdoğan

Brief Summary

Sleep disturbance is one of the most common complaints of patients admitted to ICU. Insufficient sleep in intensive care units may be associated with environmental reasons such as excessive light at night, loud warning sounds and mechanical ventilation alarms, as well as non-environmental factors, including the situation at the time of admission. Sleep assessment is subjective in nature, so it is difficult to perform in the ICU. Since communication with the patient is prevented, clear information about perceived rest and disturbing factors cannot be provided. For this reason, night rest is an issue that is often forgotten and ignored. This study applied a mixture of lavender, medicinal chamomile and neroli oil (in 20 ml of sweet almond oil; lavender oil 2 drops, medicinal chamomile 4 drops, neroli oil 6 drops) to patients who were monitored in intensive care on high-flow and oxygen, once a day for three days. This study will be conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on sleep quality.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-05
• Study First Submitted: 2024-01-11
• Status Verified: 2024-02
• Study First Submitted QC: 2024-02-28
• Last Update Submitted: 2024-02-28
• Study First Posted: 2024-03-06
• Last Update Posted: 2024-03-06
• Primary Completion: 2024-12
• Study Completion: 2024-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

• 18 years of age and over,
• Conscious patients,
• Staying in intensive care for 24 hours or more,
• Those with stable hemodynamic status,
• Receiving O2 therapy,
• Intubated patients, patients who have passed 24 hours after being extubated,
• Those whose saturation level is 85 and above

Exclusion Criteria

• Patients with peripheral neuropathy or quadriplegia,
• Patients with open wounds on their body,
• Patients receiving analgesia and sedation infusion,
• Patients who are sedated,
• Patients in delirium,
• Patients with allergies detected before starting the application

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention 2 Group	Intervention 2 Group	In this group, application is made with lavender oil.
Placebo Control Group	Placebo Control Group	In this group, application is made only with almond oil.
Intervention 1 Group	Intervention 1 Group	In this group, application is made with chamomile, lavender and neroli oil.

Primary Outcome Measures

Name	Time	Method
Patient Introduction Form	1 year	In the "Patient Introduction Form" prepared by the researcher based on the literature in order to obtain information about the characteristics of the patients who will constitute the sample, the patients' medical diagnosis, age, gender, chronic diseases, length of stay in intensive care, use of analgesic, sedative and hypnotic drugs used, normal sleep hours at night were included. There are questions about (sleep duration, daytime sleep, sleep hours, sleep aids used, etc.).

Secondary Outcome Measures

Name	Time	Method
Patient Follow-up Form	1 year	The patient follow-up form was created by the researcher and will include the visual comparison sleep scale follow-up results, the effects of the application (whether side effects develop, its effect on the application area, the patient's condition, etc.) and the dosage of the hypnotic and sedative drugs the patient took in the intensive care unit during the study. The sleep score results of the patients will be recorded on the patient follow-up form by the nurses who collected the data of the study the morning after the application (08), and the effects of the application will also be recorded by the researcher.

Trial Locations

Locations (1)

Ömer Halisdemir University Training and Research Hospital; 🇹🇷 Nigde, Turkey